HUMAN ENT1 IS PREDICTIVE OF RESPONSE IN PATIENTS WITH PANCREATIC CANCER TREATED WITH GEMCITABINE: RESULTS FROM THE RTOG 9704 PROSPECTIVE RANDOMIZED TRIAL